Table 1.
Demographic characteristics [mean (SD)] of participants who completed study by randomization sequence
| Total (n=54) | Short Sleep First (n=28) | Lona Sleep First (n=26) | |
|---|---|---|---|
| Female: % (n) | 68.5 (37) | 60.7 (17) | 76.9 (20) |
| White/Caucasian: % (n) | 64.8 (35) | 57.1 (16) | 73.1 (19) |
| Black/African American: % (n) | 14.5 (8) | 17.9 (5) | 11.5 (3) |
| Multi-racial: % (n) | 14.5 (8) | 21.4 (6) | 7.7 (2) |
| Other: % (n) | 5.5 (3) | 3.6 (1) | 7.6 (2) |
| Hispanic: % (n) | 26.9 (14) | 21.4 (6) | 32.0 (8) |
| Age: mean (SD) | 14.7 (1.6) | 14.7 (1.5) | 14.7 (1.8) |
| Grade: mean (SD) | 10.0 (1.7) | 10.0 (1.5) | 10.0 (1.9) |
| BMI: mean (SD) | 22.3 (4.1) | 22.8 (4.8) | 21.7 (3.1) |
| BMI Percentile: mean (SD) | 62.0 (27.5) | 62.3 (30.0) | 61.8 (25.0) |
| Baseline ACQ Well Controlled: % (n) | 72.2 (39) | 82.1 (23) | 61.5 (16) |
| Baseline ACQ Inadequate Control: % (n) | 9.3 (5) | 7.1 (2) | 11.5 (3) |
| Medications: % (n) | |||
| Short-Acting Bronchodilator | 70.4 (38) | 75.0 (21) | 65.4 (17) |
| Inhaled Corticoid Steroid | 35.2 (19) | 35.7 (10) | 34.6 (9) |
| Combination (ICS plus LABA) | 16.7 (9) | 17.9 (5) | 15.4 (4) |
| Leukotriene Modifier | 9.3 (5) | 7.1 (2) | 11.5 (3) |
| Biologics | 1.9 (1) | 0.0 (0) | 3.8 (1) |
| Antihistamines | 22.2 (12) | 25.0 (7) | 19.2 (5) |
| Polysomnography: mean (SD) | |||
| Sleep Efficiency | 89.7 (8.2) | 89.95 (6.5) | 89.5 (9.8) |
| Percent of N1 Sleep | 4.9 (3.6) | 4.7 (3.2) | 5.1 (4.1) |
| Percent of N2 Sleep | 57.9 (8.1) | 56.0 (8.9) | 60.0 (6.7) |
| Percent of N3 Sleep | 21.6 (8.7) | 23.5 (9.4) | 19.4 (7.6) |
| Percent of REM Sleep | 15.6 (4.3) | 15.7 (4.7) | 15.4 (3.9) |
| Obstructive Apnea Index | 1.1 (0.9) | 1.3 (1.1) | 0.9 (0.6) |
| Total RDI* | 2.1 (1.6) | 2.4 (2.0) | 1.9 (1.1) |
| SpO2 | 92.9 (1.2) | 92.8 (1.4) | 93.0 (1.1) |
*
1 subject with missing value; ACQ: Asthma Control Questionnaire